Barinthus Biotherapeutics plc. Annual Depreciation, Depletion and Amortization in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
Barinthus Biotherapeutics plc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from 2020 to 2023.
  • Barinthus Biotherapeutics plc. Depreciation, Depletion and Amortization for the quarter ending March 31, 2024 was $1.43M, a 17.1% increase year-over-year.
  • Barinthus Biotherapeutics plc. annual Depreciation, Depletion and Amortization for 2023 was $5.43M, a 25.6% increase from 2022.
  • Barinthus Biotherapeutics plc. annual Depreciation, Depletion and Amortization for 2022 was $4.32M, a 618% increase from 2021.
  • Barinthus Biotherapeutics plc. annual Depreciation, Depletion and Amortization for 2021 was $602K, a 189% increase from 2020.
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.